TF and cancer: This finding is unexpected, particularly considering the similarities that exist between the TERT promoter mutations and the DPH3-proximal mutations: DPH3 is a candidate cancer-associated gene (a potential tumour-suppressor); the mutations are recurrent in melanomas (13%); and the mutations alter a predicted ETS TF binding site [51].